Data from a new study published in the Journal of Urology indicated that administration of an FDA-approved cannabidiol, Epidiolex (GW Pharmaceuticals), did not help relieve patients’ pain after ureteroscopy.
All participants (n=90) in the randomized, double-blind, placebo-controlled study underwent ureteroscopy with stent placement for urinary stone disease (J Urol 2023;209[4]:726-733). Half of the group were randomized to placebo and the other half were given 20 mg of cannabidiol oil